Glaukos has filed a registration statement with the U.S. Securities and Exchange Commission concerning a proposed initial public offering of its common stock, the company announced in a press release.The number of shares to be offered and the price range for the proposed offering have not been determined, the release said. In addition, the company has applied to list its common stock on the New York Stock Exchange under the trading symbol “GKOS.”
By: slistl
BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation (NASDAQ: BRKR) today announced that it has secured a contract for the supply of one hundred (100) units of the DE-tector™ explosives trace detection (ETD) system for use at selected airports in Germany, including at the international Frankfurt Airport (FRA). This contract award followed the DE-tector system having successfully met the new European Civil Aviation Conference’s (ECAC) Common Evaluation Process of Security Equipment (CEP) for ai
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. today announced the appointment of Mark Iwicki as Executive Chairman and a member of its board of directors.
PARIS — At the meeting of the French Society of Ophthalmology, Dominique Brémond-Gignac, MD, PhD, talks about ocular allergies in children. There are different treatments options available and can be offered to improve the life of children and their parents.
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products for the global eye care market, today reported financial results for the three months ended March 31, 2015, and provided a business update. First Quarter 2015 and Recent Operational and Financial Highlights Grew sales of Avenova™ by 112% to $465,000 in the first quarter of 2015 over the fourth quarter of 201